BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7857355)

  • 1. Pidotimod activity against chronic bronchitis exacerbations.
    Ciaccia A
    Arzneimittelforschung; 1994 Dec; 44(12A):1516-20. PubMed ID: 7857355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis.
    Bisetti A; Ciappi G; Bariffi F; Catena E; Rocco V; Vaccaro L; Grassi V; Scarpazza G; Bertoli L; Cardani A
    Arzneimittelforschung; 1994 Dec; 44(12A):1499-502. PubMed ID: 7857351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchitis.
    Pozzi E; Dolcetti A; Orlandi O; Cirianni C; Moreo G; Piacenza G; Rampulla C; Fugazza L; Scarpazza G
    Arzneimittelforschung; 1994 Dec; 44(12A):1495-8. PubMed ID: 7857350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
    Passali D; Calearo C; Conticello S
    Arzneimittelforschung; 1994 Dec; 44(12A):1511-6. PubMed ID: 7857354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoactivity of pidotimod against episodes of recurrent tonsillitis in childhood.
    Motta G; De Campora E; De Vita C; Esposito S; Galletti C; Incutti V; Mallardi V; Motta S; Pucci V; Salonna F
    Arzneimittelforschung; 1994 Dec; 44(12A):1521-4. PubMed ID: 7857356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease.
    Benetti GP; Illeni MT; Passera A; Bombelli G; Lavecchia G; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1503-5. PubMed ID: 7857352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
    Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
    Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immunoactivation with pidotimod in recurrent respiratory infections in childhood.
    Careddu P
    Arzneimittelforschung; 1994 Dec; 44(12A):1506-11. PubMed ID: 7857353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoactivation by pidotimod in children with recurrent respiratory infections.
    Burgio GR; Marseglia GL; Severi F; De Benedetti F; Masarone M; Ottolenghi A; Pagliano L; Serra U; Nespoli L
    Arzneimittelforschung; 1994 Dec; 44(12A):1525-9. PubMed ID: 7857357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pidotimod in the treatment of recurrent respiratory infections in paediatric patients.
    Careddu P; Mei V; Venturoli V; Corsini A
    Arzneimittelforschung; 1994 Dec; 44(12A):1485-9. PubMed ID: 7857348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy and safety of pidotimod in the treatment of urinary tract infections in children.
    Clemente E; Solli R; Mei V; Cera R; Caramia G; Carnelli V; Ruffini E; Venturoli V; Corsini A
    Arzneimittelforschung; 1994 Dec; 44(12A):1490-4. PubMed ID: 7857349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo evaluation of pidotimod activity on cell-mediated immunity.
    Benetti GP; Fugazza L; Stramba Badiale M; Montalto F; Bombelli G; La Vecchia G; Illeni MT; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1476-9. PubMed ID: 7857346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antiviral effects of pidotimod.
    Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
    Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of pidotimod against experimental bacterial infections in mice.
    Coppi G; Falcone A; Manzardo S
    Arzneimittelforschung; 1994 Dec; 44(12A):1417-21. PubMed ID: 7857334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of pidotimod in elderly volunteers and in renal failure patients.
    Spotti D; Biffi M; Coppi G; Silingardi S; Mailland F
    Arzneimittelforschung; 1994 Dec; 44(12A):1470-2. PubMed ID: 7857344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulating activity of pidotimod.
    Migliorati G; Nicoletti I; Riccardi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1421-4. PubMed ID: 7857335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food on the bioavailability of pidotimod in healthy volunteers.
    D'Angelo L; De Ponti F; Crema F; Caravaggi M; Crema A
    Arzneimittelforschung; 1994 Dec; 44(12A):1473-5. PubMed ID: 7857345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental immunological screening tests on pidotimod.
    Coppi G; Manzardo S
    Arzneimittelforschung; 1994 Dec; 44(12A):1411-6. PubMed ID: 7857333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
    Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
    Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and oral bioavailability of pidotimod in humans.
    Mailland F; Coppi G; Silingardi S
    Arzneimittelforschung; 1994 Dec; 44(12A):1465-9. PubMed ID: 7857343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.